Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Revealing a novel contributing landscape of ferroptosis-related genes in Parkinson’s disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Ageing and Parkinson's disease: substantia nigra regional selectivity
10.1093/brain/114.5.2283 · 1991 · External reference
10.1002/alz.12328
10.1002/alz.12328 · External reference
Parkinson's disease in the Western Pacific Region
10.1016/s1474-4422(19)30195-4 · 2019 · External reference
10.1212/01.wnl.0000247740.47667.03
10.1212/01.wnl.0000247740.47667.03 · External reference
10.1016/s0896-6273(03)00568-3
10.1016/s0896-6273(03)00568-3 · External reference
10.1007/s00441-017-2768-8
10.1007/s00441-017-2768-8 · External reference
Gene4PD: A Comprehensive Genetic Database of Parkinson's Disease
10.3389/fnins.2021.679568 · 2021 · External reference
10.1002/mds.27659
10.1002/mds.27659 · External reference
10.1016/s1474-4422(19)30320-5
10.1016/s1474-4422(19)30320-5 · External reference
The role of genetics in Parkinson's disease: a large cohort study in Chinese mainland population
10.1093/brain/awaa167 · 2020 · External reference
Characterizing the Expression Patterns of Parkinson's Disease Associated Genes
10.3389/fnins.2021.629156 · 2021 · External reference
10.1016/j.cell.2017.09.021
10.1016/j.cell.2017.09.021 · External reference
10.1016/j.cell.2012.03.042
10.1016/j.cell.2012.03.042 · External reference
10.1523/jneurosci.3439-14.2015
10.1523/jneurosci.3439-14.2015 · External reference
10.1016/s0896-6273(00)80953-8
10.1016/s0896-6273(00)80953-8 · External reference
Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: Disease and staging biomarkers and new drug targets
10.1016/j.neulet.2016.02.011 · 2016 · External reference
10.1038/s41467-020-15109-y
10.1038/s41467-020-15109-y · External reference
Analysis of DNA methylation associates the cystine-glutamate antiporter SLC7A11 with risk of Parkinson's disease
10.1038/s41467-020-15065-7 · 2020 · External reference
10.1038/s41586-019-1705-2
10.1038/s41586-019-1705-2 · External reference
10.1016/j.pneurobio.2020.101890
10.1016/j.pneurobio.2020.101890 · External reference
Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction
10.1093/brain/awv132 · 2015 · External reference
10.1111/ejn.13760
10.1111/ejn.13760 · External reference
10.1038/ejhg.2012.129
10.1038/ejhg.2012.129 · External reference
10.1007/s00109-020-01991-y
10.1007/s00109-020-01991-y · External reference
10.1016/s1474-4422(19)30287-x
10.1016/s1474-4422(19)30287-x · External reference
10.1002/mds.28197
10.1002/mds.28197 · External reference
FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations
10.1093/database/baaa021 · 2020 · External reference
10.1016/j.arr.2017.12.007
10.1016/j.arr.2017.12.007 · External reference
10.1038/ng.3955
10.1038/ng.3955 · External reference
Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma
10.3389/fcell.2021.684259 · 2021 · External reference
10.1016/j.freeradbiomed.2019.12.026
10.1016/j.freeradbiomed.2019.12.026 · External reference
10.1073/pnas.1415518111
10.1073/pnas.1415518111 · External reference
Caveolin-1 promotes cancer progression via inhibiting ferroptosis in head and neck squamous cell carcinoma
10.1111/jop.13267 · 2022 · External reference
Rare GCH1 heterozygous variants contributing to Parkinson's disease
10.1093/brain/awx110 · 2017 · External reference
GCH1 variants contribute to the risk and earlier age-at-onset of Parkinson's disease: a two-cohort case-control study
10.1186/s40035-020-00212-3 · 2020 · External reference
10.1021/acscentsci.9b01063
10.1021/acscentsci.9b01063 · External reference
10.1016/j.freeradbiomed.2018.09.014
10.1016/j.freeradbiomed.2018.09.014 · External reference
Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson's brain
10.1186/1750-1326-6-8 · 2011 · External reference
10.1038/42166
10.1038/42166 · External reference
10.3233/jpd-179005
10.3233/jpd-179005 · External reference
A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson's disease
10.1038/s41531-021-00196-5 · 2021 · External reference
10.1016/s1474-4422(18)30179-0
10.1016/s1474-4422(18)30179-0 · External reference
Development of MAP4 Kinase Inhibitors as Motor Neuron-Protecting Agents. Cell
2019 · External reference
10.1002/jnr.22404
10.1002/jnr.22404 · External reference
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma
10.1038/s41416-018-0368-3 · 2019 · External reference
RGS4 deficit in prefrontal cortex contributes to the behaviors related to schizophrenia via system xc(-)-mediated glutamatergic dysfunction in mice
10.7150/thno.25189 · 2018 · External reference
